FDA Declines to Issue Emergency Authorization of India-Made COVAXIN for 2 to 18 Year-Olds

Ocugen, Inc., an American biopharmaceutical company focused on innovative therapies including the Covid-19 vaccine, provided an update on Friday that the Food and Drug Administration had declined its application for Emergency Use Authorization request for its Covid-19 vaccine for children ages 2 to 18 years old. According to its news release, COVAXIN™ (BBV152) is a … Continue reading FDA Declines to Issue Emergency Authorization of India-Made COVAXIN for 2 to 18 Year-Olds